Growth Metrics

Evaxion A (EVAX) Non-cash Items (2020 - 2025)

Evaxion A posted quarterly Non-cash Items of -$1.6 million for Q2 2025, up 53.34% year-on-year from -$1.0 million in Q2 2024, and up 53.34% on a QoQ basis from -$3.4 million in Q2 2024.

Evaxion A (EVAX) has 6 years of Non-cash Items data on file, last reported at -$1.6 million in Q2 2025.

  • For the quarter ending Q2 2025, Non-cash Items rose 53.34% year-over-year to -$1.6 million; the trailing twelve-month figure through Jun 2025 stood at -$1.6 million (up 53.34% YoY), and the FY2024 full-year result was -$3.1 million, down 360.62% from the prior year.
  • Non-cash Items for Q2 2025 stood at -$1.6 million, up from -$3.4 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $717000.0 in Q2 2023 and bottomed at -$3.4 million in Q2 2024.
  • The 5-year median for Non-cash Items is -$963500.0 (2021), against an average of -$1.0 million.
  • The widest annual swing landed in 2023, when Non-cash Items soared 175.55%; it then slumped 577.96% in 2024.
  • A 5-year view of Non-cash Items shows it stood at -$1.0 million in 2021, then rose by 9.27% to -$949000.0 in 2022, then jumped by 175.55% to $717000.0 in 2023, then plunged by 577.96% to -$3.4 million in 2024, then jumped by 53.34% to -$1.6 million in 2025.
  • The last three Non-cash Items figures came in at -$1.6 million (Q2 2025), -$3.4 million (Q2 2024), and $717000.0 (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Revolution Medicines 32.39 Bn 32.39 Bn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 -1.60 Mn
Jun 30, 2025 -1.60 Mn
Jun 30, 2024 -3.43 Mn
Jun 30, 2024 -3.43 Mn
Jun 30, 2023 717,000.00
Jun 30, 2023 717,000.00
Jun 30, 2022 -949,000.00
Jun 30, 2022 -949,000.00
Mar 31, 2022 -129,000.00
Mar 31, 2022 -129,000.00
Sep 30, 2021 -1.05 Mn
Sep 30, 2021 -1.05 Mn
Jun 30, 2021 -908,000.00
Jun 30, 2021 -908,000.00
Mar 31, 2021 -978,000.00
Mar 31, 2021 -978,000.00
Sep 30, 2020 1.81 Mn
Sep 30, 2020 1.81 Mn
Jun 30, 2020 735,000.00
Jun 30, 2020 735,000.00
Mar 31, 2020 507,000.00
Mar 31, 2020 507,000.00